Sign In
Buy PPH
$110.40
-1.20 (-1.08%)
At Close: Jul 31, 2026
A Look at Pharma ETFs Post Q1 Earnings
12:31pm, Tuesday, 07'th May 2024
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
12:01pm, Wednesday, 01'st May 2024
Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.
Weight-Loss Drugs Boost Case for Pharma ETFs
08:54am, Tuesday, 30'th Apr 2024
Weight-loss drugs, including Ozempic, are reshaping consumer habits. Additionally, they are providing some ballast to what's recently been a sluggish healthcare investment thesis.
PPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total Returns
04:34am, Tuesday, 23'rd Apr 2024
VanEck Pharmaceutical ETF is a popular option for investors looking for exposure to leading pharmaceutical companies. The ETF has been in an uptrend since late last year and is currently trading at a
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
11:00am, Wednesday, 17'th Apr 2024
Johnson & Johnson (JNJ) continued with its long streak of earnings beat but lagged revenue estimates.
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
04:30am, Wednesday, 17'th Apr 2024
People are interested in ETFs for weight loss because of Oprah's TV show “Shame, Blame, and the Weight Loss Revolution,” which was about weight loss drugs. A lot of people are upset that she's tal
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:21am, Friday, 08'th Mar 2024
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launc
The Top 3 ETFs to Buy in March 2024
01:43pm, Thursday, 07'th Mar 2024
Top ETFs to buy offer a smart solution for those looking to diversify their portfolios without the hassle. In the investment realm, diversification remains a key aspect of a sound investment strategy,
The 3 Hottest Healthcare ETFs to Buy in 2024
02:12pm, Monday, 26'th Feb 2024
Healthcare stocks started the year off very strongly as investors cheered the sector's advances. Among the sector's catalysts have been continued, strong enthusiasm for a new class of weight-loss drug
Pharma ETF (PPH) Hit a 52-Week High
09:50am, Monday, 19'th Feb 2024
Investors seeking momentum may have iShares VanEck Pharmaceutical ETF PPH on radar now. The fund recently hit a new 52-week high.
A Look at Pharma ETFs After Q4 Earnings
02:01pm, Monday, 12'th Feb 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs re
PPH: Ignore The Election Scare, Buy Pharma And Healthcare
07:03am, Friday, 19'th Jan 2024
Pharmaceuticals underperformed the S&P 500 in 2023 but have been outperforming the broader market in 2024. The PPH fund offers exposure to pharmaceutical stocks and has outperformed its peers in terms
Healthcare In 2024: Navigating The Biopharma Bull Run
11:22pm, Wednesday, 17'th Jan 2024
The healthcare sector presents a unique investment opportunity in 2024 due to attractive valuation and uncorrelated/robust cashflow of healthcare. Biopharma companies have pricing power and ability to
5 ETF Zones Scaling New Highs at the Start of 2024
11:17am, Monday, 08'th Jan 2024
The start of 2024 has been weak for the global stock market after a blockbuster 2023. Still, a few corners of the stock market are outperforming, pushing ETFs to new 52-week highs.
Healthcare ETFs Start 2024 on a Positive Note
01:32pm, Thursday, 04'th Jan 2024
After underperforming in 2023, the healthcare sector seems to be back on track at the start of the New Year. Healthcare generally outperforms during periods of low growth and high uncertainty.
